Amy Bachrodt, SVP of Maze Therapeutics MAZE, has filed 0 purchases and 13 sales on the open market. Over the past 12 months that comes to a net sale of $1.6M. The latest trade was on 04/01.

AB

AB

Amy Bachrodt

SVP, Finance

Company

Maze Therapeutics MAZE

First filing

25/09/24

Trades

40 trades

Buys / sales

0 / 13

12-month net buying

−$1.6M

Last trade

04/01

FollowShare

Trading activity

6 months1 year2 years5 yearsAll

Transactions

Company	Trade type	Traded	Filed	Shares	Price	Value	Holding change
Maze TherapeuticsMAZE	Open-market sale10b5-1 plan	04/01	04/02	2,500 sh2 trades	$29.44avg.	$73,606	−16.2%
Maze TherapeuticsMAZE	Open-market sale10b5-1 plan	03/02	03/03	5,000 sh2 trades	$45.20avg.	$226,011	−27.8%
Maze TherapeuticsMAZE	Open-market sale10b5-1 plan	02/02	02/04	5,000 sh3 trades	$46.04avg.	$230,215.6	−27.8%
Maze TherapeuticsMAZE	Open-market sale10b5-1 plan	01/22	01/26	5,000 sh	$45.52	$227,600	−27.8%
Maze TherapeuticsMAZE	Open-market sale10b5-1 plan	01/02	01/06	5,000 sh2 trades	$39.15avg.	$195,757.65	−27.8%
Maze TherapeuticsMAZE	Open-market sale10b5-1 plan	25/12/29–25/12/30	25/12/31	15,000 sh3 trades	$40.41avg.	$606,172	−53.6%